18. Targeting the hexosaminidase genes: Mouse models of the GM2 gangliosidoses

Advances in Genetics

Volumn 44, Issue , 2001, Pages 225-231

  Proia, Richard L ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA N ACETYLHEXOSAMINIDASE;

ANIMAL; ARTICLE; CYTOLOGY; DISEASE MODEL; EMBRYO; GENE TARGETING; GENETICS; GM2 GANGLIOSIDOSIS; HISTORY; HUMAN; METABOLISM; MOUSE; STEM CELL; TAY SACHS DISEASE;

ANIMALS; BETA-N-ACETYLHEXOSAMINIDASE; DISEASE MODELS, ANIMAL; EMBRYO; GANGLIOSIDOSES, GM2; GENE TARGETING; HISTORY, 20TH CENTURY; HUMANS; MICE; STEM CELLS; TAY-SACHS DISEASE;

EID: 0035225852     PISSN: 00652660     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0065-2660(01)44082-x     Document Type: Article

References (15)

1. M.R. Capecchi Altering the genome by homologous recombination Science 244 1989 1288 1292
2. E. Conzelmann K. Sandhoff Biochemical basis of late-onset neurolipidoses Dev. Neurosci. 13 1991 197 204
3. R.A. Gravel J.T.R. Clarke M.M. Kaback D. Mahuran K. Sandhoff K. Suzuki The GM2 gangliosidoses C.R. Scriver A.L. Beaudet W.S. Sly D. Valle The Metabolic and Molecular Basis of Inherited Disease 7th ed. 1995 McGraw-Hill New York 2839 2879
4. M. Jeyakumar T.D. Butters M. Cortina-Borja V. Hunnam R.L. Proia H.V. Perry R.A. Dwek F.M. Platt Delayed symptom onset and increased life expectancy in Sandhoff disease mice treated with N-butyldeoxynojirimycin Proc. Natl. Acad. Sci. U.S.A. 96 1999 6388 6393
5. M. Jeyakumar F. Norflus C.J. Tifft M. Cortina-Borja T.D. Butters R.L. Proia V.H. Perry R. Dwek F.M. Platt Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation Blood 97 2001 327 329
6. B.H. Koller O. Smithies Altering genes in animals by gene targeting Annu. Rev. Immunol. 10 1992 705 730
7. Y. Liu R. Wada H. Kawai K. Sango C. Deng T. Tai M.P. McDonald K. Araujo J.N. Crawley U. Bierfreund K. Sandhoff K. Suzuki R.L. Proia A genetic model of substrate deprivation therapy for a glycosphingolipid storage disorder J. Clin. Invest. 103 1999 497 505
8. E.F. Neufeld J. Muenzer The mucopolysaccharidoses C.R. Scriver A.L. Beaudet W.S. Sly D. Valle The metabolic and molecular basis of inherited disease 7th ed. 1995 McGraw-Hill New York 2465 2494
9. F. Norflus C.J. Tifft M.P. McDonald G. Goldstein J.N. Crawley A. Hoffmann K. Sandhoff K. Suzuki R.L. Proia Bone marrow transplantation prolongs life span and ameliorates neurologic manifestations in Sandhoff disease mice J. Clin. Invest. 101 1998 1881 1888
10. R.L. Proia The gene encoding the human-hexosaminidase-chain: Extensive homology of intron positions in the α and β-chain genes Proc. Natl. Acad. Sci. U.S.A. 85 1998 1883 1887
11. R.L. Proia E. Soravia Organization of the gene encoding the human β-hexosaminidase α-chain J. Biol. Chem. 262 1987 5677 5681
12. K. Sango M.P. McDonald J.N. Crawley M.L. Mack C.J. Tifft E. Skop C.M. Starr A. Hoffmann K. Sandhoff K. Suzuki R.L. Proia Mice lacking both subunits of lysosomal β-hexosaminidase exhibit mucopolysaccharidosis and gangliosidosis Nature Genet. 14 1996 348 352
13. K. Sango S. Yamanaka A. Hoffmann Y. Okuda A. Grinberg H. Westphal M.P. McDonald J.N. Crawley K. Sandhoff K. Suzuki R.L. Proia Mouse models of Tay-Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism Nature Genet. 11 1995 170 176
14. S. Yamanaka M.D. Johnson A. Grinberg H. Westphal J.N. Crawley M. Taniike K. Suzuki R.L. Proia Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease Proc. Natl. Acad. Sci. U.S.A. 91 1994 9975 9979
15. R. Wada C.J. Tifft R.L. Proia Microglial activation precedes acute eurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation Proc. Natl. Acad. Sci. U.S.A. 97 2000 10954 10959